Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2009
10/15/2009WO2009125804A1 Screening method
10/15/2009WO2009125626A1 Mesothelioma-specific promoter and use thereof
10/15/2009WO2009125607A1 Apoptosis inducer
10/15/2009WO2009125231A2 Anti-atheroma vaccine
10/15/2009WO2009099942A3 Chemically modified oligonucleotides and uses thereof
10/15/2009WO2009078931A9 Irf as a tumor suppressor and uses thereof
10/15/2009WO2009052454A3 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258935 Hybrid adeno-retroviral vector for the transfection of cells
10/15/2009US20090258933 Oligonucleotides-transferring preparations
10/15/2009US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same
10/15/2009US20090258927 Method for the Modulation of Function of Transcription Factors
10/15/2009US20090258926 Methods and Compositions for Delivering siRNA into Mammalian Cells
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258425 Gene knock-down by intracellular expression of aptamers
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258089 Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090257990 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
10/15/2009US20090257989 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
10/15/2009US20090257983 Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
10/15/2009US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
10/15/2009CA2758213A1 Anti-atheroma vaccine
10/15/2009CA2758023A1 Commensal bacteria as signal mediators within a mammalian host
10/15/2009CA2718975A1 Compositions and methods for detecting egfr mutations in cancer
10/14/2009EP2108377A1 Vascularization inhibitors
10/14/2009EP2108376A2 Prevention and treatment of amyloidogenic disease
10/14/2009EP1372710B1 Mva expressing modified hiv envelope, gag, and pol genes
10/14/2009EP1360498B1 Latent human tuberculosis diagnostic antigen and method of use
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1161548B2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101557831A Methods and sequences to suppress primate huntington gene expression in vivo
10/14/2009CN101555487A RNA interference carrier used for osteoporosis and rat mesenchymal stem cells
10/14/2009CN101555486A Application of human transcription factor HMBOX1 gene
10/14/2009CN101555469A High-efficiency recombined adenovirus containing ndrg2 gene and pharmic purpose thereof
10/14/2009CN101555468A Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555253A Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof
10/14/2009CN101554480A Improved DNA vaccines for production-type animals
10/14/2009CN101554478A Polycation nano-lipid carrier system and preparation method thereof
10/14/2009CN100549179C Stomach cancer target AFP gene siRNAs expression vector and its uses
10/14/2009CN100549165C Calcineurin of clonorchis sinensis, its coding nucleic acid and application
10/14/2009CN100549164C Recombinant virus comprising tumor therapeutic full-antibody gene with human constant region and its use
10/14/2009CN100549044C Biodegradable crosslinked polyethylenimine and its uses
10/14/2009CN100549027C Protein NMB0928 and use thereof in pharmaceutical formulations
10/14/2009CN100548385C Brucellosis nucleic acid vaccine
10/14/2009CN100548384C Genetic engineering polypeptide vaccine adjuvant for aftosa, preparation method and application thereof
10/14/2009CN100548377C Vaccine composition containing modified dendritic cells
10/13/2009US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine
10/13/2009US7601799 Methods and means to promote gut absorption
10/13/2009US7601699 Treating cells and/or nuclear transfer units and/or stem cells in culture with compounds resulting in a globally hypomethylated genome and a restoration of cell differentiation and/or developmental potential, or potentiality; decreasing S-adenosylmethione-to-S-adenosylhomocysteine ratio
10/13/2009US7601698 Polypeptide
10/13/2009US7601697 Polypeptides; nucleic acid molecules and viral vectors which direct gene expression of such polypeptides; vaccines; genetic engineering; transfecting cells of animal ex vivo with nucleic acid molecule and delivering transfected cells animal
10/13/2009US7601518 Secretion of neublastin
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601367 Delivering a siRNA to a mammal cell; low toxicity
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601345 Lentivirus vectors for gene transfer to alveolar epithelial cells
10/13/2009US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes
10/13/2009CA2318512C Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2234263C Pharmaceutical composition for treating papillomavirus tumours and infection
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/08/2009WO2009124312A2 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
10/08/2009WO2009124309A2 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
10/08/2009WO2009124137A2 Method of suppressing gene transcription through histone lysine methylation
10/08/2009WO2009124044A2 Tumor growth inhibition via conditioning of tumor microenvironment
10/08/2009WO2009123950A2 Chimera comprising bacterial cytotoxin and methods of using the same
10/08/2009WO2009123185A1 Double-stranded lipid-modified rna having high rna interference effect
10/08/2009WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009WO2009122639A1 Abc transporter protein expression inhibitor
10/08/2009WO2009121536A1 Method of treating genetic disorders
10/08/2009WO2009102894A3 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems
10/08/2009WO2009102438A3 Aptamer inhibitors of osteopontin and methods of use thereof
10/08/2009WO2009101204A3 Elimination of immune responses to viral vectors
10/08/2009WO2009094456A3 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253777 Methods of diagnosing and treating hyperproliferative disorders
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253208 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/08/2009US20090253207 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252715 Immortalization of mammalian cells
10/08/2009US20090252714 Autoantigenes for Improved Diagnosis, Prognosis and Treatment of Inflammatory Neurological Diseases
10/08/2009US20090252713 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
10/08/2009US20090252707 Novel expression vectors and uses thereof
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 870